Alteri Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
8,318
+818
+11% +$191K 0.58% 31
2026
Q1
$1.83M Buy
7,500
+334
+5% +$77.8K 0.59% 29
2025
Q4
$1.48M Buy
7,166
+18
+0.3% +$3.56K 0.48% 36
2025
Q3
$1.33M Buy
7,148
+64
+0.9% +$11K 0.46% 45
2025
Q2
$1.08M Sell
7,084
-203
-3% -$31.2K 0.42% 54
2025
Q1
$1.21M Buy
7,287
+187
+3% +$29.3K 0.53% 42
2024
Q4
$1.03M Buy
+7,100
New +$1.1M 0.28% 50

Other funds holding JNJ

Alteri Wealth's JNJ Position: Q2 2026 in Review

Alteri Wealth increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $191K and bringing the position to 8,318 shares worth $2.11M. The position accounts for 0.58% of the portfolio, ranked #31.

Alteri Wealth first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Alteri Wealth held 8,318 shares of Johnson & Johnson worth $2.11M as of Q2 2026.
  • Alteri Wealth bought 818 Johnson & Johnson shares in Q2 2026, an estimated $191K.
  • Johnson & Johnson made up 0.58% of Alteri Wealth's portfolio in Q2 2026, its #31 holding.
  • Alteri Wealth first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Alteri Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.